MERRIMACK PHARMACEUTICALS INC Proceeds from Notes Payable
MERRIMACK PHARMACEUTICALS INC reported Proceeds from Notes Payable of $14.63 million for the 12-month period ending 2018-12-31, per its 10-K filed 2020-03-12.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromNotesPayable · last filed 2020-03-12
- MERRIMACK PHARMACEUTICALS INC proceeds from notes payable for the quarter ending 2018-12-31 was $0.00.
- MERRIMACK PHARMACEUTICALS INC proceeds from notes payable for fiscal 2018 was $14.63M.
| Period end | Proceeds from Notes Payable 3 month | Proceeds from Notes Payable 9 month | Proceeds from Notes Payable 12 month |
|---|---|---|---|
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $14.63M 10-K · filed 2020-03-12 | |
| 2018-09-30 | $14.63M 10-Q · filed 2019-11-12 |